Yu Liu Ho

5PUBLICATIONS
16CO-AUTHORS
Pharmaceutical delivery technologiesChemotherapyGene and molecular therapyMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 04, 2026
Simulation Framework to Investigate Efficacy and Ocular Safety of Belantamab Mafodotin Combinations in Relapsed/Refractory Multiple Myeloma.

|Oct 07, 2025
Population Pharmacokinetics and Exposure-Response Analyses of Momelotinib, Its Active Metabolite (M21), and Total Active Moiety in Myelofibrosis.

Benjamin Rich, Meenakshi Srinivasan, Yu Liu Ho

|Sep 16, 2025
Belantamab Mafodotin with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Comprehensive Exposure-Response Analysis of the DREAMM-8 Study.

Patrick Hanafin, Yu Liu Ho, Theodoros Papathanasiou

|Aug 27, 2024
Momelotinib: Mechanism of action, clinical, and translational science.

Georgios Vlasakakis, Michael T McCabe, Yu Liu Ho

|Apr 18, 2024
Clinical assessment of momelotinib drug-drug interactions via CYP3A metabolism and transporters.

Yu Liu Ho, Pete Gorycki, Geraldine Ferron-Brady

Pageof 1

Frequent Collaborators

4 joint publications

Geraldine Ferron-Brady

3 joint publications

Georgios Vlasakakis

2 joint publications

Paul Martin

2 joint publications

Sandra A G Visser